Panel Discussion from

Digital Biomarkers and Digital Measurements Summit 2020


What Level of Evidence is Needed to Evaluate Biomarkers and Measurements?

ActiGraph
Digital Biomarkers And Digital Measurements
ActiGraph CEO, Jeremy Wyatt joins a panel of experts from HumanFirstAtlantic Council, and Samsung NeuroLogica take a deep dive and answer key questions into the evaluation of digital biomarkers and digital measurements during the discussion "What Level of Evidence is Needed to Evaluate Biomarkers and Measurements?

Discussion Panelists:

Jeremy Wyatt
Andy Coravos
Jeremy Wyatt
CEO
ActiGraph
Andy Coravos
Co-Founder and CEO
HumanFirst
Beau Woods
Ninad Gujar
Beau Woods
Deputy Director, Cyber Safety
Innovation Fellow
Atlantic Council
Ninad Gujar, PhD MBA
VP, Regulatory Affairs and
Quality Assurance
Samsung NeuroLogica

Duration: 1 Hour